SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 26.40+3.4%12:05 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (8563)2/1/1999 2:44:00 PM
From: opalapril  Read Replies (1) of 17367
 
<<At this point I think a rights offering, with registration, would be better for XOMA and shareholders than the current or past deals.>>

I don't know about that, George. Speaking for myself, Xoma has tried my patience and stretched my credulity. I would be unlikely to invest more or throw any serious money away on buying a rights offering. What I own, I own. If this company ever manages to get FDA approval for anything other than spending more money on more trials, so much the better. If it tanks, I'll walk away sufficiently wise enough not to stick with a loser this long, ever again.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext